Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    9635529 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Establishing an Inflammatory Breast Cancer Registry
Condition: Inflammatory Breast Cancer
Intervention:
2 Terminated Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
Conditions: HER2-negative Breast Cancer;   Inflammatory Breast Cancer;   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: Romidepsin;   Drug: Abraxane

Study has passed its completion date and status has not been verified in more than two years.